Embolization vs Observation for Spleen Injury
Trial Summary
What is the purpose of this trial?
This trial aims to determine if blocking blood flow to injured parts of the spleen helps patients with severe spleen injuries heal better, especially those at high risk of complications.
Research Team
Thomas Carver, MD
Principal Investigator
Medical College of Wisconsin
Eligibility Criteria
This trial is for adults over 18 with certain types of severe spleen injuries from blunt trauma. They must show specific signs on a CT scan, like contrast blush or pseudoaneurysm, and not require immediate surgery for other injuries. Excluded are those with severe brain injury, kidney disease not on dialysis, pregnant women, prisoners, or unstable vital signs upon hospital arrival.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either Splenic Artery Embolization (SAE) or Observation. SAE is performed within 6-12 hours of enrollment for those in the SAE arm.
Monitoring
Participants in the observation arm are monitored in the ICU or trauma floor for continuous care.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including evaluation of procedural complications and overall outcomes.
Treatment Details
Interventions
- Splenic Artery Embolization
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical College of Wisconsin
Lead Sponsor